Immunohistochemical detection of the anti-apoptosis protein, Survivin, predicts survival after curative resection of stage II colorectal carcinomas

Annals of Surgical Oncology

Volumn 8, Issue 4, 2001, Pages 305-310

  Sarela, Abeezar I ^a   Scott, Nigel ^a   Ramsdale, Jane ^a   Markham, Alexander F ^a   Guillou, Pierre J ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

BCL 2; Colorectal neoplasia; P53; Prognosis; Survival

Indexed keywords

SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROTEIN EXPRESSION; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; APOPTOSIS; COLORECTAL NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035011885     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-001-0305-0     Document Type: Article

References (31)

1. Molecular prognostic markers and colorectal cancer: The search goes on
2. Genetic prognostic markers for colorectal cancer
3. Survival of patients with stage B2 colon carcinoma: The Gastrointestinal Tumor Study Group experience
4. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
5. Tumour markers of prognosis in colorectal cancer
6. Apoptosis: Its significance in cancer and cancer therapy
7. Apoptosis: Its role in the progression of and chemotherapy for carcinoma
8. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
9. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
10. Control of apoptosis and mitotic spindle checkpoint by survivin
11. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
12. Novel anticancer drug discovery
13. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer
14. Expression of the anti-apoptosis gene. Survivin, predicts death from recurrent colorectal carcinoma
15. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis
16. Clinicopathological assessment and staging of colorectal cancer
17. Expression of a novel anti-apoptosis gene, survivin, correlated with tumour cell apoptosis and p53 accumulation in gastric carcinomas
18. A histopathological assessment of the response of rectal adenocarcinoma to combination chemoradiotherapy: Relationship to apoptotic activity, p53 and bcl-2 expression
19. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
20. Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer
21. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
22. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
23. Ki-ras mutation and p53 overexpression predict the clinical behaviour of colorectal cancer: A southwest oncology group study
24. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis
25. Cell proliferation and apoptosis
26. Death from early colorectal carcinomas is predicted by the presence of transcripts of the REG gene family
27. Escaping cell death: Survival proteins in cancer
28. Allelic loss of chromosome 18q and prognosis in colorectal cancer
29. The DCC protein and prognosis in colorectal cancer
30. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
31. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer